Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact

Subscribe

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Zacin 0.025% w/w Cream PA23369/005/001

Capsaicin

Ennogen Healthcare (Europe) Limited

Marketed

ZADENVI 60 mg solution for injection in pre-filled syringe EU/1/25/1937/001

Denosumab

—

Zaditen 0.25 mg/ml, eye drops, solution PA1107/010/001

KETOTIFEN FUMARATE

Laboratoires Thea

Marketed

Zaditen 1 mg Tablets PA2206/004/002

KETOTIFEN FUMARATE

Alfasigma S.p.A

Marketed

Zaditen 1mg/5ml oral solution PA2206/004/001

Ketotifen hydrogen fumarate

Alfasigma S.p.A

Marketed

Zafrilla 2mg tablets PA1330/023/001

Dienogest

Gedeon Richter Plc

Marketed

Zalasta 10 mg Orodispersible tablet EU/1/07/415/42-46

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 10 mg Tablet EU/1/07/415/16-21

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 15 mg Orodispersible tablet EU/1/07/415/47-51

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 15 mg Tablet EU/1/07/415/22-26

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 2.5 mg Tablet EU/1/07/415/1-5

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 20 mg Orodispersible tablet EU/1/07/415/52-56

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 20 mg Tablet EU/1/07/415/27-31

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 5 mg Orodispersible tablet EU/1/07/415/32-36

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 5 mg Tablet EU/1/07/415/006

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 7.5 mg Orodispersible tablet EU/1/07/415/37-41

Olanzapine

KRKA, d.d., Novo mesto

—

Zalasta 7.5 mg Tablet EU/1/07/415/11-15

Olanzapine

KRKA, d.d., Novo mesto

—

ZALTRAP 25 mg/ml concentrate for solution for infusion EU/1/12/814/001-003

Aflibercept

Sanofi Winthrop Industrie

—

Zanaflex 2 mg Tablets PA0749/054/001

Tizanidine

Teva Pharma B.V.

Marketed

Zanaflex 2 mg Tablets PPA0465/474/001

Tizanidine

PCO Manufacturing Ltd.

—

Zanaflex 2 mg Tablets PPA1463/224/001

Tizanidine

IMED Healthcare Ltd.

—

Zanaflex 4 mg Tablets PA0749/054/002

Tizanidine

Teva Pharma B.V.

Marketed

Zanaflex 4 mg Tablets PPA0465/474/002

Tizanidine

PCO Manufacturing Ltd.

—

Zanaflex 4 mg Tablets PPA1463/224/002

Tizanidine

IMED Healthcare Ltd.

—

Zanidip 10 mg film-coated tablets PA0812/001/001

Lercanidipine hydrochloride

Recordati Industria Chimica e Farmaceutica SpA

Marketed

Zanidip 10 mg film-coated tablets PPA0465/481/001

Lercanidipine hydrochloride

PCO Manufacturing Ltd.

Not marketed

Zanidip 10 mg film-coated tablets PPA1463/203/001

Lercanidipine hydrochloride

IMED Healthcare Ltd.,

—

ZANIDIP 10 mg Film-coated Tablets PPA23080/034/001

Lercanidipine hydrochloride

Merit Pharmaceuticals Limited

—

Zanidip 20 mg film-coated tablets PPA0465/481/002

Lercanidipine hydrochloride

PCO Manufacturing Ltd.

—

Zanidip 20 mg film-coated tablets PPA1463/203/002

Lercanidipine hydrochloride

IMED Healthcare Ltd.,

—

ZANIDIP 20 mg Film-coated Tablets PPA23080/034/002

Lercanidipine hydrochloride

Merit Pharmaceuticals Limited

—

Zanidip 20mg film-coated tablets PA0812/001/002

Lercanidipine hydrochloride

Recordati Industria Chimica e Farmaceutica SpA

Marketed

Zarontin 250 mg/5 ml Syrup PA22644/005/001

Ethosuximide

Essential Pharma (M) Limited

Marketed

Zarontin 250 mg/5 ml Syrup PPA0465/456/001

Ethosuximide

PCO Manufacturing Ltd.

—

Zarontin 250 mg/5 ml Syrup PPA1463/181/001

Ethosuximide

IMED Healthcare Ltd.,

—

Zarontin 250mg/5ml Syrup PPA2306/031/001

Ethosuximide

Originalis B.V.

—

Zarzio 30 MU (60 MU/ml) Solution for injection or EU/1/08/495/1-4,9-12

Ep2006 (recombinant human granulocyte-colony stimulating factor)

—

Zarzio 48 MU (96 MU/ml) Solution for injection or EU/1/08/495/5-8,13-16

Ep2006 (recombinant human granulocyte-colony stimulating factor)

—

Zavedos 1 mg/ml solution for injection PA0822/142/005

Idarubicin hydrochloride

Pfizer Healthcare Ireland Unlimited Company

Marketed

Zavesca 100 mg capsules EU/1/02/238/001

Miglustat

Advanz Pharma Limited

—

Zavicefta 2 g/0.5 g powder for concentrate for solution for infusion EU/1/16/1109/001

Avibactam sodium, Ceftazidime pentahydrate

Pfizer Ireland Pharmaceuticals

—

Zebinix 200 mg Tablet EU/1/09/514/021-023

Eslicarbazepine acetate

BIAL-Portela & Ca, S.A.

—

Zebinix 400 mg Tablet EU/1/09/514/1-6

Eslicarbazepine acetate

BIAL-Portela & Ca, S.A.

—

Zebinix 50 mg/ml Oral suspension EU/1/09/514/024

Eslicarbazepine acetate

BIAL-Portela & Ca, S.A.

—

Zebinix 600 mg Tablet EU/1/09/514/7-11

Eslicarbazepine acetate

BIAL-Portela & Ca, S.A.

—

Zebinix 800 mg Tablet EU/1/09/514/12-20

Eslicarbazepine acetate

BIAL-Portela & Ca, S.A.

—

Zedbac 500 mg powder for concentrate for solution for infusion PA23142/010/001

Azithromycin dihydrate

Aspire Pharma (Malta) Limited

Not marketed

Zeffix 100 mg Film-coated tablet EU/1/99/114/001

Lamivudine

GlaxoSmithKline Trading Services Limited

—

Zeffix 100 mg Film-coated tablet EU/1/99/114/002

Lamivudine

GlaxoSmithKline Trading Services Limited

—

Zeffix 5 mg/ml Oral solution EU/1/99/114/003

Lamivudine

GlaxoSmithKline Trading Services Limited

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.